Newsletter
Q1 2022 Newsletter
- NOL Webinar: The Journey Towards Personalized Anesthesia
- NOL Simulation Hub
- NOL in the ICU
Q4 2021 Newsletter
- NOL at the American Society of Anesthesiologists (ASA) Meeting
- TopMedTalk with professor Anil Hormis
- NOL and BIS infographic
- New case report
- Conference highlights
Q3 2021 Newsletter
- Discover new features and content on our website
- Meet us at Anesthesiology 2021
- Why clinicians use NOL: Video highlights
- Pipeline: Harnessing AI technology for clinic and home monitoring
- Our vision in 90 seconds
Q2 2021 Newsletter
- Register for our NOL EXPLORE webinar series for clinicians
- Clinical Experience Papers now available
- New Study in the European Journal of Anaesthesiology
- Access the full live event on “Managing Intraoperative Nociception and Personalising Analgesia”
- Strengthening the Clinician's NOLedge!
Q1 2021 Newsletter
- Join our Live Interactive NOL Programme for HCPs
- Watch this webinar: Improving Analgesia Management
- Reducing hospital costs with intraoperative NOL monitoring
- New clinical study: Predicting postop pain
- #PainTalk - follow the conversation on nociception monitoring on social media
Q4 2020 Newsletter
- Virtual NOL talks
- New NOL evidence for the New Year!
- Case report: NOL monitoring in spine surgery
- How we continue supporting and guiding users around the world
- Approved for marketing in Brazil
Q3 2020 Newsletter
- Accelerating Growth: Medasense Raises $18M Series C
- Study shows: NOL Monitoring Can Reduce Postoperative Pain
- How NOL reduces hospital costs
- Recently published case reports and expert lectures
- 'Ask the Anesthesiologist' for Pain Awareness Month
Q2 2020 Newsletter
- NOL Webinar: Into the Future of Pain Management
- New study explores NOL utilization for ICU mechanically ventilated patients
- Latest case reports: COVID-19
- Going remote with Medasense Academy
- Leadership, innovation and vision: be inspired!
Q1 2020 Newsletter
- Introducing new NOL features
- Pain response monitoring for dementia patients
- Simulation training - coming soon!
- Find NOL in new regions and facilities
- Take some time out for Medasense Academy
Q4 2019 Newsletter
- Welcome to our new website!
- NOL from the surgeon's perspective
- See NOL in action during surgery
- NOL around the world
- New case reports now available
Q3 2019 Newsletter
- The essence of Medasense in a one-minute clip
- Clinicians reflect on the importance of nociception monitoring
- New lectures examine how NOL monitoring helps guide drug titration
- Introducing new commercial territories
- Medasense Academy – our online education hub
Q2 2019 Newsletter
- NOL talk at conferences in Europe and Latin America
- How anaesthesiologists are utilizing NOL (video)
- Clinical results you should know about
- Introducing Medasense Academy
- One of 50 best-in-class startups
Q1 2019 Newsletter
- Clinical outcomes you should know about
- Looking forward to seeing you in Germany!
- ESA is around the corner
- Driven by patient outcomes
- Expanding global presence
Q4 2018 Newsletter
- First clinical outcome study shows positive results in evaluating the role of the NOL technology in guiding opioid administration during surgery for improved outcomes.
- NOL is now included in the new Intensive Care Unit International Guidelines.
- An insightful editorial review, covering all the available nociception monitoring technologies, published recently in the Minerva Anestesiologica publication.
Q3 2018 Newsletter
- Visit us at Anesthesiology 2018, 13-15 Oct.
- New abstract presentations share the potential impact of NOL on patient outcomes.
- New published studies.
- Thank you to everyone who stopped by the Medtronic booth at SFAR (our distribution partner in France) and joined the NOL symposia & workshop.
- NOL technology is now commercially available in Australia.
Q2 2018 Newsletter
- Visit us at Euroanaesthesia 2018, 2-4 June
- NOL can guide the choice of opioids versus sympatholytic administration, according to latest abstract presented at NEARC
- First NOL Symposium in Romania
- Thank you for visiting us at HOSPITALAR
- NOL is now officially a registered trademark!
Q1 2018 Newsletter
- NOL technology is now commercially available across Europe, Israel and… Canada!
- Watch world experts talk about the NOL technology and its benefits
- Scientific publications and presentations
- Medasense wins CEWIT 2017 Startup Contest
- Medasense making waves in China
Top Posts
Medasense Welcomes Holly Stewart as VP of Sales, North America
Medasense
December 4, 2023
FDA Commissioner Highlights Marketing Authorization of NOL Technology
Medasense
September 21, 2023
Now in the U.S. – Meet us at U.S. conferences
Medasense
August 30, 2023
NoCamels publishes article on the benefits of nociception monitoring with the NOL Technology
Medasense
April 16, 2023